Bone-Growth Product Lawsuits Could Cost Medtronic, Inc. Up To $140 Million

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Medtronic Inc. will record a charge between $120 million and $140 million for hundreds of lawsuits over its Infuse bone-growth product, the company said Tuesday. The Fridley-based medical-device maker already agreed to pay $22 million to settle suits from 950 claimants. Medtronic did not admit wrongdoing or liability in the settlement.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC